PRESS RELEASE – November 2025 A research team from the Institute for Clinical and Health Effectiveness (IECS) has established an objective framework for 182 countries that allows for anticipating the magnitude of the impact of introducing a new drug, vaccine, diagnostic test, biomedical device, or other technology or intervention on available resources […]
Lipoprotein(a)—also known as Lp(a)—is becoming an emerging marker of cardiovascular risk, generating increasing interest among researchers and healthcare professionals. Its more frequent inclusion in clinical practice guidelines reinforces the need to update knowledge about its epidemiology and its interpretation in practice.
Specialists analyze the future of Lipoprotein (a) in a new IECS webinar See more "
OCTOBER 2025SEE FULL NEWSLETTER By Dr. Viviana E. Rodriguez* Antimicrobial resistance (AMR) is a priority threat to public health, driven by the inappropriate use of antimicrobials in human health, animal health, agriculture, and their dissemination in the environment. In 2019, an estimated 4,95 million deaths were related to AMR.
Antimicrobial resistance: a threat requiring immediate and collaborative action See more "
The Institute for Clinical and Healthcare Effectiveness (IECS) is launching a regional call for professionals working in the management of health research funds in Latin America. We seek to form a group of members who will promote Bridge to Excellence Grants & Research Management, a pioneering community of practices that connects specialists to share experiences.
On Thursday, July 3, 2025, the webinar "Implementation of Strategies to Improve the Control of High Blood Pressure in Latin America" was held. This virtual, open, and free event was aimed at healthcare professionals, researchers, and members of civil society interested in chronic diseases and public health. The event
The Institute for Clinical and Health Effectiveness (IECS) endorses a letter recently published in The Lancet in support of the key role of the World Health Organization (WHO) in global public health. The document was signed by the directors of nearly 800 WHO Collaborating Centres worldwide.
The IECS endorses an open letter in support of the WHO See more "
In the fast-paced global health landscape, the quest for transparent, equitable, and fair health systems is more urgent than ever. And health technology assessments (HTAs), with their mission to ensure transparency in decision-making, can play a role as a catalyst for more equitable and sustainable health systems.
How can HTAs be used to achieve more transparent, equitable, and fair health systems? See more "
Mere "gatekeepers" or shapers? Health technology assessment (HTA) is increasingly challenged to transcend its traditional role in evaluating new drugs, devices, or tests to become a more proactive catalyst for the transformation of health systems, actively influencing their configuration. The topic was the subject of
Plenary Session II, “NextGen Methods: Hype or Here to Stay?”, opened the next day of the HTAi (Health Technology Assessment International) International Congress. More than 800 stakeholders from the health sector and health technology assessment are participating in the meeting in Buenos Aires, with
Under the central theme “NextGen Evidence: Diversifying and Advancing Health Technology Assessment (HTA) to Meet Global Demands” and with the participation of more than 800 delegates from some 80 countries, the Annual Congress of HTAi (Health Technology Assessment international) —HTAi 2025— began in Buenos Aires, the main global meeting that brings together
